How can OncuraKit help someone with an inconclusive PSA, mammogram, or colonoscopy?

Inconclusive results from standard cancer screenings — PSA in the 4–10 ng/mL 'gray zone,' BI-RADS 3 mammogram findings, or colorectal polyps of uncertain significance — leave patients in a difficult position: the result is abnormal enough to worry but not definitive enough to act on immediately. OncuraKit provides orthogonal molecular information: if cancer-associated miRNA is also elevated, this strengthens the case for expedited follow-up (biopsy, additional imaging, specialist referral). If OncuraKit is normal, it provides additional reassurance alongside the inconclusive traditional result and may support a watchful waiting approach rather than immediate invasive workup. OncuraKit does not replace the follow-up clinical decision-making but provides additional data to inform that decision.